Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research engagement with Altillion, Inc. ("Altillion") an innovator in lithium brine processing. During this project, Telescope Innovations applied its proprietary ReCRFT™...
2024-09-17 8:00 AM EDT
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research collaboration with Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) ("Standard Lithium"). Over the past year, Telescope Innovations and Standard Lithium have worked...
2024-08-28 8:00 AM EDT
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the execution of a master collaborative research agreement (the "Agreement") with Pfizer Inc. ("Pfizer"). Under the multi-year Agreement, Pfizer and Telescope will collaboratively develop technology to help potentially...
2024-07-31 8:00 AM EDT
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology...
2024-07-22 1:43 PM EDT
Telescope Innovations Presents Results of Third Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2024. The Company generated revenues of $1.2 million during this period (Q3, 2024). Telescope's corresponding fiscal year-to-date revenues exceed $3.4 million and surpass the...
2024-07-11 8:37 PM EDT
Telescope Innovations Joins MaRS: North America's Largest Urban Innovation Hub
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member of MaRS Discovery District, ("MaRS") a network of the most promising and innovative young technology companies in Canada. As North America's largest urban innovation hub, MaRS empowers member companies to...
2024-06-24 8:00 AM EDT
Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation the 2024 Lithium Supply and Battery Raw Materials Conference hosted by Fastmarkets. The conference will take place on June 24-27 in Las Vegas, NV. Dr. Ryan Jansonius, VP of Chemistry Contract Services...
2024-06-11 8:00 AM EDT
Telescope Innovations to Showcase DirectInject-LC(TM) Product and Process IP at METTLER TOLEDO Events
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation in two "InfoDays" sponsored by METTLER TOLEDO. Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays. InfoDays are high-profile industry and academia networking...
2024-05-13 8:00 AM EDT
Telescope Innovations Presents Results of Second Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results and operational highlights for the fiscal quarter ended February 29, 2024. The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product,...
2024-04-18 8:02 PM EDT
Telescope Innovations Develops Novel Battery Recycling Technology
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is leading a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has demonstrated proof-of-concept for a proprietary recrystallization process that...
2024-04-15 8:00 AM EDT
Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces that it is engaged in a technology integration partnership with Shimadzu Scientific Instruments, Inc. ("Shimadzu"). Shimadzu is a global leader in analytical instrumentation for chemistry research and development, and the partners aim to...
2024-02-26 8:00 AM EST
Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairman and Chief Executive Officer and John Kirincic as Chief Financial Officer for the Company. Jason Hein will continue to lead Telescope's development services and research efforts as Chief Technology...
2024-02-15 8:00 AM EST
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC(TM)
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreement with METTLER TOLEDO (NYSE: MTD) for Telescope's online chemistry sampling and analysis product, the DirectInject-LC™. METTLER TOLEDO is a global leader of precision instruments and services, including...
2024-02-05 8:00 AM EST
Telescope Innovations Presents Results of First Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2023. The Company generated revenues of $1.50 M for a net income of $215,000 (Figure 1).
2024-01-30 8:00 AM EST
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has filed a provisional patent application (63/606,069) on a disruptive new technique to...
2024-01-23 8:00 AM EST
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal year ended August 31, 2023. The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.
2023-12-22 3:11 PM EST
Telescope Innovations Develops New IP for the Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces it has filed a provisional patent application (65/584,062) on the production of lithium sulfide, a key precursor for next-generation solid-state batteries. As an outcome of work with Standard Lithium Ltd., Telescope has...
2023-12-18 8:00 AM EST
Telescope Innovations and Mott Corporation Initiate Technology Partnership
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, announces that it has signed a Memorandum of Understanding ("MOU") partnership with Mott Corporation ("Mott"). Mott is a top technology-driven, precision filtration company, and the partners aim to commercialize a novel robotic sampling probe...
2023-10-30 8:00 AM EDT
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, is excited to announce that its flagship product for automated analysis of chemical reactions, Direct Inject Liquid Chromatography (DILCTM), is quickly being established in the market as a critical tool to support process development. One year...
2023-10-04 8:00 AM EDT
Telescope Innovations Is Granted a Canadian Patent on Chemical Synthesis Route
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been granted a Canadian patent, through its wholly-owned subsidiary, for a scalable manufacturing process to produce pharmaceutically-relevant indole compounds. Telescope developed this process in response to globally rising...
2023-08-28 8:00 AM EDT